Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr;10(2):104-106.
doi: 10.21037/cdt.2019.08.08.

Iliofemoral lysis for DVT remains ATTRACTive

Affiliations
Editorial

Iliofemoral lysis for DVT remains ATTRACTive

Catherine Go et al. Cardiovasc Diagn Ther. 2020 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/cdt.2019.08.08). EDA has received speaking honoraria from Boston Scientific Corporation. CG has no conflicts of interest to declare.

Comment on

  • Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis.
    Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, Jaff MR, Razavi MK, Kindzelski AL, Bashir R, Patel P, Sharafuddin M, Sichlau MJ, Saad WE, Assi Z, Hofmann LV, Kennedy M, Vedantham S; ATTRACT Trial Investigators. Comerota AJ, et al. Circulation. 2019 Feb 26;139(9):1162-1173. doi: 10.1161/CIRCULATIONAHA.118.037425. Circulation. 2019. PMID: 30586751 Free PMC article. Clinical Trial.

References

    1. Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017;377:2240-52. 10.1056/NEJMoa1615066 - DOI - PMC - PubMed
    1. Comerota AJ, Kearon C, Gu CS, et al. Endovascular thrombus removal for acute iliofemoral deep vein thrombosis. Circulation 2019;139:1162-73. 10.1161/CIRCULATIONAHA.118.037425 - DOI - PMC - PubMed
    1. Enden T, Haig Y, Kløw NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012;379:31-8. 10.1016/S0140-6736(11)61753-4 - DOI - PubMed
    1. O'Sullivan GJ, de Graaf R, Black SA. Just how attractive is the ATTRACT trial? Cardiovasc Intervent Radiol 2018;41:1313-7. 10.1007/s00270-018-2016-y - DOI - PubMed
    1. Avgerinos ED, Chaer RA. The ATTRACTiveness of catheter-directed thrombolysis. J Vasc Surg Venous Lymphat Disord 2018;6:303. 10.1016/j.jvsv.2018.02.002 - DOI - PubMed